intensive week of practices in the CNIO

During this week we have been visited by seven students of the Master of Molecular Oncology. Thanks to our e-learning platform, these students from different Latin American countries have been enjoying our online masters and make the same practices […]

I Forum of medical oncology at 3 days

Today begins the first forum gives medical oncology in Spain. With this purely academic initiative aims to bring the latest results of medical oncology oncologists, residents, hospital pharmacists, clinical studies coordinators and nurses […]

Descubierto un nuevo mecanismo capaz de promover la tumorigénesis

The director of the Master of Molecular Oncology and a researcher at Harvard University, Dr. Pier Paolo Pandolfi, leading research published in the journal Cell on how RNA generated from oncogenic chromosomal translocations are […]

New therapeutic target for aggressive endometrial cancer

Dr.. Jose Palacios, professor of molecular oncology Masters, He has led a project that demonstrates further progress on the importance of Hippo via confer more aggressive endometrial tumors. This results, published in the […]

Marker that predicts the risk of relapse in patients with lung cancer

Currently there are no targeted therapies for the treatment of non-small cell lung tumors with squamous histology based on the molecular profile of cancer, so it is key to identify specific alterations, potential therapeutic targets and markers […]

Delaying aging thanks to the body's antioxidant defenses

Dr.. Manuel Serrano, Professor of our Master of Molecular Oncology, and his team have published a new study in the journal Nature Communications about as the overall increase in antioxidant defenses could delay aging […]

Development of new models to study immunotherapy

New treatment precision Lymphomas

The director of the Master of Molecular Oncology, Dr. Miguel Angel Piris and his team, just published an article in the American Journal of Surgical Pathology where they study the importance of identifying patients with lymphoma […]

Advances in the treatment of lung cancer

El profesor del Máster de Oncología Molecular, Dr. Mariano Barbacid, leading research published in the prestigious journal Nature Medicine where researchers demonstrate how the use of a combination drug therapy with inhibitors of DDR1 and Noch1, dasatinib […]

Cancer Day is a time to support research

Today is World Cancer Day and we want to add to it with the great contributions they are making our teachers to identify improvements in treatment, diagnosis and quality of life of cancer patients. Cancer […]